RDA Financial Network’s AstraZeneca AZN Stock Holding History

RDA Financial Network’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$206K	Buy	1,085 +15	+1%	+$2.82K	0.04%	282
2026 Q1	$211K	Sell	1,070 -51	-5%	-$9.83K	0.05%	260
2025 Q4	$206K	Buy	+1,121	New	+$197K	0.05%	261

Other funds holding AZN

Evelyn Partners London $46.9B AUM

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

RDA Financial Network's AZN Position: Q2 2026 in Review

RDA Financial Network increased its AstraZeneca (AZN) stake by 1.4% in Q2 2026, buying an estimated $2.82K and bringing the position to 1,085 shares worth $206K. The position accounts for 0.04% of the portfolio, ranked #282.

RDA Financial Network first reported a position in AZN in Q4 2025 and has held it in 3 quarters since. The position peaked at $211K in Q1 2026. 1,502 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

RDA Financial Network held 1,085 shares of AstraZeneca worth $206K as of Q2 2026.
RDA Financial Network bought 15 AstraZeneca shares in Q2 2026, an estimated $2.82K.
AstraZeneca made up 0.04% of RDA Financial Network's portfolio in Q2 2026, its #282 holding.
RDA Financial Network first reported a position in AstraZeneca in Q4 2025 and has held it in 3 quarters since.
RDA Financial Network's AstraZeneca position peaked at $211K in Q1 2026.
1,502 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on RDA Financial Network's 13F filing for Q2 2026, filed 6 Jul 2026.